Clinical Trials Logo

Clinical Trial Summary

Patients undergoing first time cardiac surgery will undergo rapid atrial pacing prior to initiation of cardiopulmonary bypass to screen for AF inducibility. Patients with inducible AF will be randomized to prophylactic amiodarone treatment versus no treatment. Patients who are not inducible to AF will be treated with standard post-operative care. Patients will be monitored post-operatively to explore the value of intraoperative inducibility of AF to predict POAF and to evaluate whether the combination of intraoperative inducibility and precision amiodarone therapy is effective at reducing the incidence of POAF


Clinical Trial Description

In the operating room, as part of the open heart surgery, the surgeon will stimulate the superior right atrium section of the heart with a pacemaker for 30 seconds just prior to starting the heart and lung bypass machine. The stimulation is done to see how sensitive the heart is to developing atrial fibrillation. This test result will be documented. The procedure will only take 60 seconds out of the entire operation. It does not involve taking any samples of tissue or blood. Following this step, if the heart demonstrates atrial fibrillation for at least 30 seconds then the participant will then be randomized to either receive the prophylactic drug treatment using Amiodarone or to no prophylactic drug administration. The participant has a 50% chance of receiving the FDA approved study drug Amiodarone. The study arms consist of prophylactic drug administration with Amiodarone, No prophylactic drug administration, or no atrial fibrillation reaction after stimulation with the pacemaker. The remainder of the surgical procedure will not be affected, and will follow routine surgical practice. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03868150
Study type Interventional
Source Stanford University
Contact Anson Lee, MD
Phone 650-724-7500
Email ansonlee@stanford.edu
Status Recruiting
Phase Phase 4
Start date March 1, 2017
Completion date December 31, 2050

See also
  Status Clinical Trial Phase
Recruiting NCT03857711 - Randomized Clinical Trial PULVAB (Prophylactic Pulmonary Veins Ablation) N/A
Completed NCT02132767 - Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation Phase 3
Completed NCT01742039 - Prevention of Postoperative Atrial Fibrillation
Recruiting NCT06151652 - Effect of Alpha-Lipoic Acid Supplementation on the Incidence of Postoperative Atrial Fibrillation in Cardiac Surgery Patients Phase 4
Recruiting NCT05076019 - Statin Therapy With Atorvastatin in Surgical Aortic Valve Replacement N/A
Completed NCT03646773 - Microvascular Effects of Intravenous Esmolol During Postoperative Atrial Fibrillation
Completed NCT00765089 - Bipolar Radiofrequency Ablation -Role in Prevention of Postoperative Atrial Fibrillation Phase 4
Recruiting NCT05730413 - Once Versus Twice Bisoprolol Dosage Regimen in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft Surgery Phase 4
Completed NCT04307225 - Atrial Fibrillation After CABG and PCI
Not yet recruiting NCT05009914 - A New Way of Cardiac Denervation to Reduce the Incidence of AF After CABG. N/A
Recruiting NCT03905759 - Prophylaxis Against Postoperative Atrial Fibrillation in Patients Undergoing On-pump CABG Phase 2/Phase 3
Recruiting NCT06054360 - Predictive Value of Right Atrial Strain in Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
Recruiting NCT05320705 - The Effect of Intra Operative Dexmedetomidine in Prevention of Early Postoperative Atrial Fibrillation Phase 1
Recruiting NCT05062239 - Post-Operative Atrial Fibrillation After Surgical Aortic Valve Replacement and the Influence of Statins N/A